Drugmakers discontinue TV ads for Vytorin

01/22/2008 | Forbes · Advertising Age (tiered subscription model)

Merck & Co. and Schering-Plough Corp. are removing television ads for their cholesterol-lowering drug Vytorin after study results showed the drug to be no more effective than its high-dose generic component. "We've made the decision to voluntarily and temporarily suspend direct-to-consumer broadcast advertising in light of mischaracterization and misinterpretation of the enhanced trial results," a representative for the drugmakers explained. Print ads for the product will continue to run, he said.

View Full Article in:

Forbes · Advertising Age (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ